Affiliation:
1. KARAMANOĞLU MEHMETBEY ÜNİVERSİTESİ TIP FAKÜLTESİ
Abstract
Aims: CRISPR/Cas9, a revolutionary genome editing tool derived from a bacterial system, has transformed molecular biology research, enabling precise and versatile modifications to the genome. This study surveyed 300 participants, including instructors, second-year medical students, and patient relatives from Selcuk University Faculty of Medicine, to assess their knowledge, attitudes, and ethical perspectives on gene editing.
Methods: A comprehensive survey was conducted, and the participants' demographics were correlated with their responses. Statistical analysis was performed using SPSS 22.0.
Results: The survey revealed significant differences (p<0.05) in attitudes based on gender, age, and participation groups. The age group of 18-29 exhibited the highest participation rate (57.3%), while the age group of 60-65 had the lowest (1%). Approximately 50.3% of participants reported no prior knowledge of CRISPR/Cas9, and 64.3% were university graduates. Obtaining approval from ethics committees was considered crucial by 151 respondents for commencing CRISPR/Cas9 research. Interestingly, 63.3% showed eagerness for genetically modified plants and animals, while only 9% expressed interest in studies related to eternal youth. Additionally, 88% found gene editing studies conflicting with their beliefs.
Conclusions: CRISPR/Cas9 holds great promise for biomedicine and healthcare but necessitates enhanced public awareness and informed decision-making. The study highlights the importance of promoting informed discussions on the ethical implications of CRISPR/Cas9 to address the concerns and perceptions of various demographics. These valuable insights contribute to the ongoing discourse on the impact of CRISPR/Cas9 on society.
Funder
No funding was received by the author.
Reference15 articles.
1. Didovyk A, Borek B, Tsimring L, Hasty J. Transcriptional regulation with CRISPR-Cas9: principles, advances, and applications. Current Opinion in Biotechnology. 2016; 40(Supplement C):177-84.
2. Singh V, Braddick D, Dhar PK Exploring the potential of genome editing CRISPR-Cas9 technology. Gene. 2017;599 (Supplement C):1-18.
3. Knight S, Tjian R, Doudna J. Genomes In Focus: Development And Applıcatıons Of Crıspr-Cas9 Imagıng Technologıes. Angewandte Chemie International Edition. 2017:1-21.
4. HÄYry M. Synthetic Biology and Ethics: Past, Present, and Future. Cambridge Quarterly of Healthcare Ethics. 2017;26(2):186-205.
5. Baker B. The Ethics of Changing the Human Genome. BioScience. 2016;66(4):267-73.